Depreciation in USD of Protagenic Therapeutics, Inc.\new from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Depreciation history and growth rate from 2014 to Q3 2025.
  • Protagenic Therapeutics, Inc.\new Depreciation for the quarter ending September 30, 2025 was $12.6K.
  • Protagenic Therapeutics, Inc.\new Depreciation for the twelve months ending September 30, 2025 was $62.9K, a 21.4% increase year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2024 was $50.3K, a 78.2% increase from 2023.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2023 was $28.2K, a 93960% increase from 2022.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2022 was $30.000.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Protagenic Therapeutics, Inc.\new Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $62.9K $12.6K +$12.6K Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-26
Q2 2025 $50.3K $12.6K $0 0% Apr 1, 2025 Jun 30, 2025 10-QT 2025-09-10
Q1 2025 $50.3K $12.6K $0 0% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $50.3K $25.1K -$1.48K -5.54% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $51.8K $0 -$1.42K -100% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-26
Q2 2024 $53.2K $12.6K +$12.5K +13714% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $40.7K $12.6K +$12.5K +13869% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $28.2K $26.6K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $1.42K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $91.00 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $90.00 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2020 $84.00 -$1 -1.18% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $85.00 -$4 -4.49% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-18
Q1 2018 $89.00 -$828 -90.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-16
Q1 2017 $917 +$835 +1018% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $82.00 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15

Protagenic Therapeutics, Inc.\new Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $50.3K +$22.1K +78.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $28.2K +$28.2K +93960% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $30.00 Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2020 $286 -$53 -15.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-07
2019 $339 -$8 -2.31% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $347 +$199 +134% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-29
2017 $148 -$386 -72.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $534 +$391 +273% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $143 -$237 -62.4% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-05-08
2014 $380 Jan 1, 2014 Dec 31, 2014 8-K/A 2016-07-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.